Board meeting on 4 Aug to consider Q1 FY27 results and final dividend record date

Revenue growth above 20%Profit growth above 25%EBITDA margin expansionResults View source PDF Explain this filing

MOREPENLAB · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

+4.8%Reaction day

₹55.20

prior close

₹55.79

announcement price

After-mkt

timing

Nifty Microcap 250market · in no size index; the smallest one is used+0.5%+4.3% vs market

Pharmaceuticals peers, median of 160sector+0.8%+4.0% vs sector

On the reaction day the stock moved 4.3 pts more than Nifty Microcap 250 and 4.0 pts more than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

+0.1

10m

+0.4

15m

+0.0

30m

+0.3

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

+4.8+0.5+4.3+0.8+4.0

Next day

+1.7-0.1+1.8-0.0+1.7

+2.9+1.0+2.0+0.1+2.9

+4.0+2.3+1.7+0.6+3.4

+25.3+2.8+22.6+1.0+24.3

+38.9+4.1+34.9+0.6+38.3

+44.9+4.5+40.4+1.5+43.4

15d

+60.1+4.8+55.4+0.3+59.8

+94.5+6.4+88.1+1.9+92.6

+115.3+5.5+109.8+3.3+112.0

+116.1-1.7+117.8-2.2+118.4

UpDownMarket · Nifty Microcap 250Sector · Pharmaceuticals peers, median of 160Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Morepen Laboratories has scheduled a board meeting on 4 August 2026 to consider and approve un-audited standalone and consolidated financial results for the quarter ended 30 June 2026 (Q1 FY27). The board will also fix the record date for determining members eligible to receive the final dividend for the financial year ended 31 March 2026. The trading window remains closed until 6 August 2026 for designated persons and their immediate relatives.

Likely market impact

Investors should watch for Q1 FY27 earnings on or after 4 August and details on the final dividend record date, which determines dividend eligibility.

By the numbersConsolidated · Q1 FY27 vs Q1 FY26

	Q1 FY27	Q1 FY26	Change
Revenue	₹570.1 Cr	₹425.2 Cr	+34.1%
Operating profit	₹69.34 Cr	₹11.11 Cr	+524.3%
Profit after tax	₹56.40 Cr	₹10.75 Cr	+424.7%
EBITDA margin	14.5%	5.7%	+8.8 pp

From the company's XBRL filing, not from the text above. Operating profit = profit before tax − exceptional items − other income. EBITDA = profit before tax + finance costs + depreciation − other income.